Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
Solomon Habtemariam, Ioana Berindan-Neagoe, Maciej Banach, Mahdi Bagheri, Morteza Izadi, Emilio Clementi, Mahsa Rasekhian, Mohammad Bagheri, Seyed Nabavi, Cosmin Cismaru